Total GluA1 expression was assessed for both groups via western blot, and no difference was detected (FXS C1: mean = 0.61 ± 0.04, FXS C1-cKO: mean = 0.58 ± 0.036, p = 0.730) (Figure 4C). The gene discussed is GRIA1; the disease is fragile X syndrome.